44PCorrelation between an automated functional assay that predicts targeted agent (TA) sensitivity and the tumor response of the sorafenib treatment evaluated within the MOST clinical trial. - Tredan, O; Zelichov, O; Barbash, Z; Daitsh, Y; Birnbaum, L; Tarcic, G; You, B; Cassier, P; Fouchardiere, C de la; Ray-Coquard, I L (Annals of Oncology, 2018)